Alacizumab is a humanized monoclonal antibody expressed in Chinese Hamster Ovary (CHO) cells, specifically designed to target VEGFR2/KDR/CD309. This antibody is comprised of a human IgG1 heavy chain and a human kappa light chain, resulting in a predicted molecular weight of 144.08 kDa. For experimental control purposes, Human IgG1 kappa, Isotype Control is recommended. Alacizumab is applicable in research focused on angiogenesis and vascular biology due to its specificity in binding to VEGFR2/KDR/CD309, a critical receptor in vascular endothelial growth factor (VEGF) signaling pathways.
Alacizumab is a humanized monoclonal antibody expressed in Chinese Hamster Ovary (CHO) cells, specifically designed to target VEGFR2/KDR/CD309. This antibody is comprised of a human IgG1 heavy chain and a human kappa light chain, resulting in a predicted molecular weight of 144.08 kDa. For experimental control purposes, Human IgG1 kappa, Isotype Control is recommended. Alacizumab is applicable in research focused on angiogenesis and vascular biology due to its specificity in binding to VEGFR2/KDR/CD309, a critical receptor in vascular endothelial growth factor (VEGF) signaling pathways.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
